Guardant Health (GH) is an oncology company that uses its proprietary blood tests, vast data sets and advanced analytics to fight cancer. The stock had a big run-up into early 2021 but has been in a downward trend since then. Let's check out the charts and indicators to see what may lie ahead for Guardant.
In this daily bar chart of GH, below, I see a downtrend in the past year with a downside price gap on huge trading volume that cannot be ignored -- it's pretty dramatic. Prices trade below the bearish 50-day and bearish 200-day moving average lines. The daily On-Balance-Volume (OBV) is bearish as sellers have been more aggressive than buyers the past year. The Moving Average Convergence Divergence (MACD) oscillator is below the zero line, telling us that the trend strength is weak.